SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark Life Scienc - Quaterly Results

20 Oct 2023 Evaluate
A fair growth of 16.90% in the revenue at Rs. 5953.63 millions was reported in the September 2023 quarter as compared to Rs. 5092.99 millions during year-ago period.Net profit stood at Rs. 1187.37  millions  compared to Rs. 1068.78 millions in the corresponding previous quarter,high by 11.10%.The company reported a good operating profit of 1724.53 millions compared to 1536.59 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 5953.63 5092.99 16.90 11738.13 9991.69 17.48 21612.20 21232.14 1.79
Other Income 53.69 100.20 -46.42 72.20 195.13 -63.00 289.57 147.04 96.93
PBIDT 1724.53 1536.59 12.23 3674.65 3099.20 18.57 6712.50 6307.64 6.42
Interest 3.99 1.33 200.00 7.95 2.68 196.64 5.47 279.62 -98.04
PBDT 1720.54 1535.26 12.07 3666.70 3096.52 18.41 6707.03 6028.02 11.26
Depreciation 131.29 99.35 32.15 257.41 198.14 29.91 420.94 378.77 11.13
PBT 1589.25 1435.91 10.68 3409.29 2898.38 17.63 6286.09 5649.25 11.27
TAX 401.88 367.13 9.47 867.42 742.27 16.86 1616.48 1462.01 10.57
Deferred Tax 14.88 28.20 -47.23 44.43 41.05 8.23 110.37 85.74 28.73
PAT 1187.37 1068.78 11.10 2541.87 2156.11 17.89 4669.61 4187.24 11.52
Equity 245.05 245.05 0.00 245.05 245.05 0.00 245.05 245.05 0.00
PBIDTM(%) 28.97 30.17 -3.99 31.31 31.02 0.93 31.06 29.71 4.55

Alivus Life Sciences Share Price

1066.65 -6.50 (-0.61%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×